Savior Lifetec
Savior Lifetec Corporation, a specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations. The company provides various carbapenem generic drugs and injections, such as paliperidone palmitate, cetrorelix and ganirelix acetate, plecanatide, prucalopride succinate, and brinzolamide. It offers imipenem and cilastatin, mero… Read more
Savior Lifetec (4167) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.028x
Based on the latest financial reports, Savior Lifetec (4167) has a cash flow conversion efficiency ratio of 0.028x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$102.24 Million) by net assets (NT$3.69 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Savior Lifetec - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Savior Lifetec's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Savior Lifetec Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Savior Lifetec ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sunny Friend Environmental Technology Co Ltd
TW:8341
|
0.039x |
|
Advanced Process Systems Corporation
KQ:265520
|
0.038x |
|
WEYCO GRP INC. DL 1
F:WY1
|
N/A |
|
Joyvio Agriculture Development Co Ltd
SHE:300268
|
-0.016x |
|
Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
|
-0.076x |
|
PT Bangun Kosambi Sukses Tbk
JK:CBDK
|
0.019x |
|
Baoding Dongli Machinery Co.Ltd.
SHE:301298
|
N/A |
|
Zhejiang Taifu Pump Co. Ltd
SHE:300992
|
0.101x |
Annual Cash Flow Conversion Efficiency for Savior Lifetec (2011–2024)
The table below shows the annual cash flow conversion efficiency of Savior Lifetec from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$3.52 Billion | NT$518.38 Million | 0.147x | +27.87% |
| 2023-12-31 | NT$3.36 Billion | NT$387.95 Million | 0.115x | -33.27% |
| 2022-12-31 | NT$3.37 Billion | NT$581.77 Million | 0.173x | +440.04% |
| 2021-12-31 | NT$3.31 Billion | NT$-168.34 Million | -0.051x | -285.45% |
| 2020-12-31 | NT$3.33 Billion | NT$91.25 Million | 0.027x | -61.21% |
| 2019-12-31 | NT$2.21 Billion | NT$156.40 Million | 0.071x | +169.06% |
| 2018-12-31 | NT$1.86 Billion | NT$-189.84 Million | -0.102x | -184.82% |
| 2017-12-31 | NT$2.16 Billion | NT$260.89 Million | 0.121x | +435.93% |
| 2016-12-31 | NT$2.12 Billion | NT$-76.09 Million | -0.036x | +86.25% |
| 2015-12-31 | NT$1.59 Billion | NT$-415.82 Million | -0.261x | -265.61% |
| 2014-12-31 | NT$1.29 Billion | NT$-92.41 Million | -0.071x | -16.66% |
| 2013-12-31 | NT$1.39 Billion | NT$-85.39 Million | -0.061x | +65.70% |
| 2012-12-31 | NT$1.27 Billion | NT$-227.59 Million | -0.179x | +48.89% |
| 2011-12-31 | NT$1.31 Billion | NT$-458.82 Million | -0.349x | -- |